Elderly patients with glomerular diseases and IgA nephropathy

Jing Lin, Zhen Cheng, Qi Qian

Research output: Contribution to journalReview article

Abstract

As the population ages, greater numbers of elderly patients will present with kidney diseases. Many kidney diseases, such as IgA nephropathy, will require kidney biopsy for diagnostic confirmation, treatment guidance and prognostication. In this paper, we review the current and expected future healthcare landscape with a focus on the ageing population, pros and cons of kidney biopsy in elderly patients, as well as treatment strategies and precautions. We also review the available data on IgA nephropathy in the elderly, including its occurrence rate based on the kidney biopsy, clinicohistopathological features, differentiation with IgA-dominant postinfectious glomerulonephritis, treatment options and outcome prediction. Overall, information on kidney diseases in patients with advanced age, including IgA nephropathy, is limited. Clinical evaluation and management strategies are extrapolated largely from studies in younger adults. Age-specific clinical and translational investigations of kidney diseases are eminently needed.

Original languageEnglish (US)
Pages (from-to)20-26
Number of pages7
JournalNephrology
Volume22
DOIs
StatePublished - Dec 1 2017

Fingerprint

Kidney Diseases
Immunoglobulin A
Kidney
Biopsy
Glomerulonephritis
Population
Young Adult
Delivery of Health Care
Therapeutics

Keywords

  • elderly
  • glomerular diseases
  • IgA nephropathy
  • kidney biopsy for elderly
  • risk prediction

ASJC Scopus subject areas

  • Nephrology

Cite this

Elderly patients with glomerular diseases and IgA nephropathy. / Lin, Jing; Cheng, Zhen; Qian, Qi.

In: Nephrology, Vol. 22, 01.12.2017, p. 20-26.

Research output: Contribution to journalReview article

Lin, Jing ; Cheng, Zhen ; Qian, Qi. / Elderly patients with glomerular diseases and IgA nephropathy. In: Nephrology. 2017 ; Vol. 22. pp. 20-26.
@article{36fb49e4a570475fbbbc20f0b3ddc6fe,
title = "Elderly patients with glomerular diseases and IgA nephropathy",
abstract = "As the population ages, greater numbers of elderly patients will present with kidney diseases. Many kidney diseases, such as IgA nephropathy, will require kidney biopsy for diagnostic confirmation, treatment guidance and prognostication. In this paper, we review the current and expected future healthcare landscape with a focus on the ageing population, pros and cons of kidney biopsy in elderly patients, as well as treatment strategies and precautions. We also review the available data on IgA nephropathy in the elderly, including its occurrence rate based on the kidney biopsy, clinicohistopathological features, differentiation with IgA-dominant postinfectious glomerulonephritis, treatment options and outcome prediction. Overall, information on kidney diseases in patients with advanced age, including IgA nephropathy, is limited. Clinical evaluation and management strategies are extrapolated largely from studies in younger adults. Age-specific clinical and translational investigations of kidney diseases are eminently needed.",
keywords = "elderly, glomerular diseases, IgA nephropathy, kidney biopsy for elderly, risk prediction",
author = "Jing Lin and Zhen Cheng and Qi Qian",
year = "2017",
month = "12",
day = "1",
doi = "10.1111/nep.13144",
language = "English (US)",
volume = "22",
pages = "20--26",
journal = "Nephrology",
issn = "1320-5358",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Elderly patients with glomerular diseases and IgA nephropathy

AU - Lin, Jing

AU - Cheng, Zhen

AU - Qian, Qi

PY - 2017/12/1

Y1 - 2017/12/1

N2 - As the population ages, greater numbers of elderly patients will present with kidney diseases. Many kidney diseases, such as IgA nephropathy, will require kidney biopsy for diagnostic confirmation, treatment guidance and prognostication. In this paper, we review the current and expected future healthcare landscape with a focus on the ageing population, pros and cons of kidney biopsy in elderly patients, as well as treatment strategies and precautions. We also review the available data on IgA nephropathy in the elderly, including its occurrence rate based on the kidney biopsy, clinicohistopathological features, differentiation with IgA-dominant postinfectious glomerulonephritis, treatment options and outcome prediction. Overall, information on kidney diseases in patients with advanced age, including IgA nephropathy, is limited. Clinical evaluation and management strategies are extrapolated largely from studies in younger adults. Age-specific clinical and translational investigations of kidney diseases are eminently needed.

AB - As the population ages, greater numbers of elderly patients will present with kidney diseases. Many kidney diseases, such as IgA nephropathy, will require kidney biopsy for diagnostic confirmation, treatment guidance and prognostication. In this paper, we review the current and expected future healthcare landscape with a focus on the ageing population, pros and cons of kidney biopsy in elderly patients, as well as treatment strategies and precautions. We also review the available data on IgA nephropathy in the elderly, including its occurrence rate based on the kidney biopsy, clinicohistopathological features, differentiation with IgA-dominant postinfectious glomerulonephritis, treatment options and outcome prediction. Overall, information on kidney diseases in patients with advanced age, including IgA nephropathy, is limited. Clinical evaluation and management strategies are extrapolated largely from studies in younger adults. Age-specific clinical and translational investigations of kidney diseases are eminently needed.

KW - elderly

KW - glomerular diseases

KW - IgA nephropathy

KW - kidney biopsy for elderly

KW - risk prediction

UR - http://www.scopus.com/inward/record.url?scp=85034595262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034595262&partnerID=8YFLogxK

U2 - 10.1111/nep.13144

DO - 10.1111/nep.13144

M3 - Review article

C2 - 29155502

AN - SCOPUS:85034595262

VL - 22

SP - 20

EP - 26

JO - Nephrology

JF - Nephrology

SN - 1320-5358

ER -